NXGN · Nextgen Healthcare, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $653.17M | $596.35M | $556.82M | $540.24M | $509.62M | $492.48M |
| Cost of Revenue | $342.01M | $295.40M | $275.42M | $267.44M | $246.70M | $241.53M |
| Gross Profit | $311.16M | $300.95M | $281.40M | $272.80M | $282.48M | $289.48M |
| R&D | $82.30M | $76.66M | $75.50M | $83.30M | $80.99M | $81.26M |
| SG&A | $223.42M | $209.66M | $180.53M | $165.17M | $164.88M | $193.23M |
| Total Operating Expenses | $315.02M | $294.29M | $268.58M | $267.69M | $250.86M | $286.66M |
| D&A | $5.09M | $6.90M | $8.00M | $8.17M | $10.30M | $10.50M |
| Operating Income | ($3.87M) | $6.66M | $12.82M | $5.11M | $31.62M | $2.82M |
| Interest Expense | $6.30M | $1.50M | $3.52M | $1.96M | $2.81M | $3.32M |
| Income Tax | $6.96M | $3.58M | ($240.0K) | ($3.24M) | $4.79M | ($2.83M) |
| Net Income | ($2.65M) | $1.62M | $9.52M | $7.50M | $24.49M | $2.42M |
| EPS - Basic | ($0.04) | $0.02 | $0.14 | $0.11 | $0.38 | $0.04 |
| EPS - Diluted | ($0.04) | $0.02 | $0.14 | $0.11 | $0.38 | $0.04 |
Balance Sheet
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $98.72M | $59.83M | $73.30M | $138.01M | $33.08M | $28.84M |
| Accounts Receivable | $88.50M | $76.06M | $77.54M | $80.01M | $87.46M | $84.96M |
| Inventory | - | - | - | - | $180.0K | $158.0K |
| Accounts Payable | $12.02M | $9.13M | $11.38M | $10.52M | $5.43M | $4.21M |
| Current Assets | $401.82M | $211.57M | $207.64M | $260.01M | $159.85M | $141.66M |
| Total Assets | $896.10M | $627.67M | $644.49M | $720.12M | $532.89M | $515.75M |
| Current Liabilities | $198.11M | $180.86M | $180.63M | $143.22M | $128.23M | $134.59M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $495.67M | $204.60M | $212.84M | $319.62M | $156.95M | $192.34M |
| Stockholders' Equity | $400.44M | $423.08M | $431.64M | $400.49M | $375.95M | $323.41M |
| Retained Earnings | $127.60M | $130.25M | $128.63M | $119.12M | $111.62M | $78.71M |
Cash Flow
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $43.66M | $53.55M | $98.52M | $85.60M | $50.48M | $76.59M |
| Investing Cash Flow | ($216.89M) | ($28.08M) | ($28.55M) | ($96.07M) | ($25.52M) | ($91.53M) |
| Financing Cash Flow | $212.62M | ($37.29M) | ($131.72M) | $116.27M | ($21.65M) | $6.12M |
| CapEx | $2.28M | $2.58M | $3.76M | $7.45M | $4.95M | $9.80M |
| Free Cash Flow | $41.38M | $50.96M | $94.76M | $78.15M | $45.52M | $66.78M |
Ratios
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 47.6% | 50.5% | 50.5% | 50.5% | 55.4% | 58.8% |
| Operating margin | -0.6% | 1.1% | 2.3% | 0.9% | 6.2% | 0.6% |
| EBITDA margin | 0.2% | 2.3% | 3.7% | 2.5% | 8.2% | 2.7% |
| Net margin | -0.4% | 0.3% | 1.7% | 1.4% | 4.8% | 0.5% |
| Free cash flow margin | 6.3% | 8.5% | 17.0% | 14.5% | 8.9% | 13.6% |
| FCF / Net income | -15.59 | 31.50 | 9.96 | 10.42 | 1.86 | 27.60 |
| R&D / Revenue | 12.6% | 12.9% | 13.6% | 15.4% | 15.9% | 16.5% |
| SG&A / Revenue | 34.2% | 35.2% | 32.4% | 30.6% | 32.4% | 39.2% |
| Effective tax rate | 161.7% | 68.9% | -2.6% | -76.1% | 16.4% | - |
| Return on assets | -0.3% | 0.3% | 1.5% | 1.0% | 4.6% | 0.5% |
| Return on equity | -0.7% | 0.4% | 2.2% | 1.9% | 6.5% | 0.7% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 2.03 | 1.17 | 1.15 | 1.82 | 1.25 | 1.05 |
| Quick ratio | 2.03 | 1.17 | 1.15 | 1.82 | 1.25 | 1.05 |
| Cash ratio | 0.50 | 0.33 | 0.41 | 0.96 | 0.26 | 0.21 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | -0.6x | 4.4x | 3.6x | 2.6x | 11.2x | 0.8x |
| Equity multiplier | 2.24 | 1.48 | 1.49 | 1.80 | 1.42 | 1.59 |
| Liabilities / Assets | 0.55 | 0.33 | 0.33 | 0.44 | 0.29 | 0.37 |
| Efficiency | ||||||
| Asset turnover | 0.73 | 0.95 | 0.86 | 0.75 | 0.96 | 0.95 |
| Inventory turnover | - | - | - | - | 1370.54 | 1528.70 |
| Days sales outstanding | 49d | 47d | 51d | 54d | 63d | 63d |
| Days inventory outstanding | - | - | - | - | 0d | 0d |
| Days payable outstanding | 13d | 11d | 15d | 14d | 8d | 6d |
| Cash conversion cycle | - | - | - | - | 55d | 57d |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 9.5% | 7.1% | - | 6.0% | 3.5% | 0.5% |
| Revenue CAGR (3y) | - | 3.3% | 3.0% | 3.3% | 4.6% | 2.3% |
| Revenue CAGR (5y) | 5.1% | 3.9% | 2.6% | 3.3% | - | - |
| Gross profit growth (YoY) | 3.4% | 6.9% | - | -3.4% | -2.4% | 1.0% |
| Operating income growth (YoY) | - | -48.1% | - | -83.8% | 1020.8% | -89.6% |
| Net income growth (YoY) | - | -83.0% | - | -69.4% | 912.1% | -86.7% |
| EPS growth (YoY) | - | -85.7% | - | -71.1% | 850.0% | -86.2% |
| EPS CAGR (3y) | - | -43.3% | -28.3% | -27.6% | 61.6% | -55.4% |
| EPS CAGR (5y) | - | -12.9% | -13.6% | -24.6% | 7.9% | -85.9% |
| FCF growth (YoY) | -18.8% | -46.2% | - | 71.7% | -31.8% | -32.1% |
| FCF CAGR (5y) | -1.9% | -5.3% | -0.8% | 0.5% | -13.5% | - |
| Book value growth (YoY) | -5.4% | -2.0% | - | 6.5% | 16.2% | 6.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2023-03-31.
Product / service
$1.31B totalRecurring Revenue$593.92M · 45.5%
Subscription Services$184.05M · 14.1%
Support And Maintenance$153.52M · 11.8%
Managed Services$129.12M · 9.9%
Transactional And Data Services$127.24M · 9.7%
Software Hardware And Other Non Recurring$59.25M · 4.5%
Other Non Recurring Services$31.39M · 2.4%
Software License And Hardware$27.86M · 2.1%
Stability scores
Altman Z′
FY 2023 · bankruptcy risk
1.34
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2023 · 9-point quality
4/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Services-Computer Integrated Systems Design
Comparing NEXTGEN HEALTHCARE against the 5 most active filers in the same SIC group.